Average Co-Inventor Count = 4.69
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eisai R&d Management Co., Ltd. (4 from 530 patents)
2. Eisai Company, Limited (1 from 677 patents)
3. National Cancer Center (1 from 222 patents)
4. Eisai Inc. (1 from 33 patents)
6 patents:
1. 12364690 - Therapeutic agent for bile duct cancer
2. 11160783 - Multikinase inhibitors for use in the treatment of cancer
3. 9549922 - Use of eribulin and lenvatinib as combination therapy for treatment of cancer
4. 8937056 - Multikinase inhibitors for use in the treatment of cancer
5. 8609640 - Multikinase inhibitors for use in the treatment of cancer
6. 6649367 - Human cancer cell line malignantly altered by expression of angiogenic factor